CoviDx OTC
Total Payments
$34,460
Transactions
1
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $34,460 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $34,460 | 1 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| CoviDx OTC | Rapid Pathogen Screening, Inc. | $34,460 | 0 |
Top Doctors Receiving Payments for CoviDx OTC
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Tampa, FL | $34,460 | 1 |
Ad
Manufacturing Companies
- Rapid Pathogen Screening, Inc. $34,460
Product Information
- Type Device
- Total Payments $34,460
- Total Doctors 0
- Transactions 1
About CoviDx OTC
CoviDx OTC is a device associated with $34,460 in payments to 0 healthcare providers, recorded across 1 transactions in the CMS Open Payments database. The primary manufacturer is Rapid Pathogen Screening, Inc..
Payment data is available from 2022 to 2022. In 2022, $34,460 was paid across 1 transactions to 0 doctors.
The most common payment nature for CoviDx OTC is "Unspecified" ($34,460, 100.0% of total).
CoviDx OTC is associated with 1 research study, including "CoviDx OTC" ($34,460).